Does LEUPROLIDE Cause Product physical consistency issue? 926 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 926 reports of Product physical consistency issue have been filed in association with LEUPROLIDE (Fensolvi). This represents 1.3% of all adverse event reports for LEUPROLIDE.
926
Reports of Product physical consistency issue with LEUPROLIDE
1.3%
of all LEUPROLIDE reports
1
Deaths
0
Hospitalizations
How Dangerous Is Product physical consistency issue From LEUPROLIDE?
Of the 926 reports, 1 (0.1%) resulted in death.
Is Product physical consistency issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 926 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Product physical consistency issue?
CLASCOTERONE (317)
BUPRENORPHINE (242)
MINOXIDIL (171)
CHOLESTYRAMINE (141)
NAPROXEN (117)
TESTOSTERONE (113)
RUXOLITINIB (103)
DEVICE (85)
CLOBETASOL (76)
POLYETHYLENE GLYCOL 3350 (69)
Which LEUPROLIDE Alternatives Have Lower Product physical consistency issue Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM